mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.34 |
6e-22 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.32 |
6e-19 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.28 |
3e-17 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-15 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-13 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-12 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
7e-12 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.32 |
4e-11 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
7e-11 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
3e-10 |